Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria

Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria

Background: Metabolic syndrome (MS) is a global epidemic that has great socioeconomic and public health implications. This study reports observed effects of the Shexiang Baoxin Pill (SBP) in a rat model of MS and explores its underlying mechanisms of action.Methods: A diet-induced rat model of MS wa...

Full description

Bibliographic Details
Main Authors: Dan Wei, Ningning Zheng, Lanyan Zheng, Leting Wang, Liang Song, Luning Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Pharmacology
Subjects:
metabolic syndrome
Shexiang Baoxin Pill
lipid metabolism
inflammation
mitochondrial proteins
reactive oxygen species
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2018.00137/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2018.00137/full

Similar Items